Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients

被引：4
作者：
Fu, Junliang [1 ]
Zhang, Ji-Yuan [1 ]
Wang, Fu-Sheng [1 ]
机构：
[1] Beijing 302 Hosp, Res Ctr Biol Therapy, Inst Translat Hepatol, Beijing 100039, Peoples R China
来源：
HEPATOLOGY INTERNATIONAL | 2014年 / 8卷 / 01期
关键词：
SORAFENIB; CELLS; INHIBITION; ACIDS;
D O I：
10.1007/s12072-013-9493-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 19 条
[1]   Phase II study of sorafenib in patients with advanced hepatocellular carcinoma [J].
Abou-Alfa, Ghassan K. ;
Schwartz, Lawrence ;
Ricci, Sergio ;
Amadori, Dino ;
Santoro, Armando ;
Figer, Arie ;
De Greve, Jacques ;
Douillard, Jean-Yves ;
Lathia, Chetan ;
Schwartz, Brian ;
Taylor, Ian ;
Moscovici, Marius ;
Saltz, Leonard B. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4293-4300
[2]   Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial [J].
Bruix, Jordi ;
Raoul, Jean-Luc ;
Sherman, Morris ;
Mazzaferro, Vincenzo ;
Bolondi, Luigi ;
Craxi, Antonio ;
Galle, Peter R. ;
Santoro, Armando ;
Beaugrand, Michel ;
Sangiovanni, Angelo ;
Porta, Camillo ;
Gerken, Guido ;
Marrero, Jorge A. ;
Nadel, Andrea ;
Shan, Michael ;
Moscovici, Marius ;
Voliotis, Dimitris ;
Llovet, Josep M. .
JOURNAL OF HEPATOLOGY, 2012, 57 (04) :821-829
[3]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[4]   New progress of non-surgical treatments for hepatocellular carcinoma [J].
Cheng, Ji-Wen ;
Lv, Yi .
MEDICAL ONCOLOGY, 2013, 30 (01)
[5]   Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective [J].
Colombo, Massimo ;
Raoul, Jean-Luc ;
Lencioni, Riccardo ;
Galle, Peter R. ;
Zucman-Rossi, Jessica ;
Banares, Rafael ;
Seehofer, Daniel ;
Neuhaus, Peter ;
Johnson, Philip .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (06) :639-651
[6]   Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update [J].
Gauthier, Angela ;
Ho, Mitchell .
HEPATOLOGY RESEARCH, 2013, 43 (02) :147-154
[7]   BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect [J].
Hallahan, AR ;
Pritchard, JI ;
Chandraratna, RAS ;
Ellenbogen, RG ;
Geyer, JR ;
Overland, RP ;
Strand, AD ;
Tapscott, SJ ;
Olson, JM .
NATURE MEDICINE, 2003, 9 (08) :1033-1038
[8]   Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors [J].
Iwata, M ;
Eshima, Y ;
Kagechika, H .
INTERNATIONAL IMMUNOLOGY, 2003, 15 (08) :1017-1025
[9]   An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma [J].
Kanai, Fumihiko ;
Obi, Shuntaro ;
Fujiyama, Shigetoshi ;
Shiina, Shuichiro ;
Tamai, Hideyuki ;
Mochizuki, Hitoshi ;
Koike, Yukihiro ;
Imamura, Jun ;
Yamaguchi, Takayoshi ;
Saida, Isamu ;
Yokosuka, Osamu ;
Omata, Masao .
HEPATOLOGY INTERNATIONAL, 2014, 8 (01) :94-103
[10]   Synthetic Retinoid AM80 Inhibits Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis [J].
Klemann, Christian ;
Raveney, Benjamin J. E. ;
Klemann, Anna K. ;
Ozawa, Tomoko ;
von Hoersten, Stephan ;
Shudo, Koichi ;
Oki, Shinji ;
Yamamura, Takashi .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (06) :2234-2245
12